reports
Donna Karan New York Presents The Edit, the Spring 2026 Campaign Featu...
Donna Karan New York Presents The Edit, the Spring 2026 Campaign Featuring Adriana Lima, Joan Smalls and Grace Elizabeth NEW YORK, Feb. 12, 2026 (GLOBE NEWSWIRE) -- Donna Karan New York continues its reemergence with The Edit: a curated fashion campaign shaped by three women whose presence transcends trend, age, and moment. Adriana Lima, Joan Smalls, and Grace Elizabeth bring their distinct points of view to the brand’s design DNA, selecting and styling a personal edit from the wider collection for an intimate dialogue between women and their wardrobes. Highlighting the talents’ pe...
Xilio Therapeutics Announces Pricing of Underwritten Offering
Xilio Therapeutics Announces Pricing of Underwritten Offering WALTHAM, Mass., Feb. 11, 2026 (GLOBE NEWSWIRE) -- Xilio Therapeutics, Inc. (Nasdaq: XLO), a clinical-stage biotechnology company discovering and developing masked immuno-oncology therapies for people living with cancer, today announced the pricing of an underwritten offering of pre-funded warrants to purchase 74,780,300 shares of common stock at a price to investors of $0.5349 per pre-funded warrant (the “pre-funded warrants”). Each pre-funded warrant is exercisable for one share of common stock at an exercise price of $0.0001 ...
DKNY Reveals Its Spring 2026 Campaign Featuring Hailey Bieber
DKNY Reveals Its Spring 2026 Campaign Featuring Hailey Bieber NEW YORK, Feb. 10, 2026 (GLOBE NEWSWIRE) -- The icon is back: Hailey Bieber returns as the global face of DKNY, continuing last season’s breakthrough fashion story with a new, high-impact campaign. For Spring 2026, the disruptive art scene of downtown New York in the ’60s sets the stage for a fresh spin on the recreation of an icon. Expanding on fame as an art form, the campaign places Hailey at the center of a black-and-white photo series of herself while wearing looks from the latest collection. The campaign concept tak...
- Wedbush Research
SIMON SILICON MOTION TECHNOLOGY CORPORATION SPONSORED ADR
PSTG PURE STORAGE INC. CLASS A
NVDA NVIDIA CORPORATION
NTAP NETAPP INC.
MU MICRON TECHNOLOGY INC.
MNKD MANNKIND CORP.
INTC INTEL CORPORATION
GOOGL ALPHABET INC. CLASS A
FB FACEBOOK INC. CLASS A
BIIB BIOGEN INC.
AXTI AXT INC.
NFLX NETFLIX INC.
2330 TAIWAN SEMICONDUCTOR MANUFACTURING CO. LTD.
2303 UNITED MICROELECTRONICS CORP.
AMD ADVANCED MICRO DEVICES INC.
AAPL APPLE INC.
MSFT MICROSOFT CORPORATION
UBER UBER TECHNOLOGIES INC.
SMCI SUPER MICRO COMPUTER
APRE INC.
NUVB APREA THERAPEUTICS
STX NUVATION BIO INC (A)
GFS SEAGATE TECHNOLOGY HLDGS PLC
SLDB GLOBALFOUNDRIES INC
SOLID BIOSCIENCES INC
- David Nierengarten
- Dennis Pak
- Martin Fan
Paramount Gold Receives Federal Approval for the Grassy Mountain Gold ...
Paramount Gold Receives Federal Approval for the Grassy Mountain Gold Project WINNEMUCCA, Nev., Jan. 29, 2026 (GLOBE NEWSWIRE) -- Paramount Gold Nevada Corp. (NYSE American: PZG) (“Paramount” or the “Company”) announced today that the Record of Decision (“ROD”) for its Grassy Mountain Gold Project (“Grassy Mountain”), located in Malheur County, Oregon has been signed. The issuance of the ROD represents the culmination of the federal environmental review process under the National Environmental Policy Act (“NEPA”). The Final Environmental Impact Statement (FEIS) incorporates feedback rece...
- Wedbush Research
GOOGL ALPHABET INC. CLASS A
GERN GERON CORP.
BMRN BIOMARIN PHARMACEUTICAL INC.
BCRX BIOCRYST PHARMACEUTICALS INC.
ACRS ACLARIS THERAPEUTICS INC.
PTGX PROTAGONIST THERAPEUTICS
ARGX ARGENX ADS
ISR ISORAY
AAPL APPLE INC.
APLS APELLIS PHARMACEUTICALS
SRRK SCHOLAR ROCK HOLDING CORPORATION
KNSA KINIKSA PHARMACEUTICALS
ORIC ORIC PHARMACEUTICALS
COGT COGENT BIOSCIENCES INC
NUVB NUVATION BIO INC (A)
PL PLANET LABS PBC
GMTX GEMINI THERAPEUTICS INC
MLTX MOONLAKE IMMUNOTHERAPEUTICS
NUVL NUVALENT INC
SYRE SPYRE THERAPEUTICS INC.
ORKA ORUKA THERAPEUTICS INC
BCAX BICARA THERAPEUTICS INC.
- David Nierengarten
- Dennis Pak
- Martin Fan
Xilio Therapeutics Highlights Upcoming Milestones and Recent Corporate...
Xilio Therapeutics Highlights Upcoming Milestones and Recent Corporate Updates Received $35.8 million in gross proceeds from Series B warrant exercises, including full exercise by Coastlands Capital, Frazier Life Sciences and Gilead Sciences, Inc., and extended anticipated cash runway into second quarter of 2027 Achieved development milestone for masked antibody-based program under AbbVie agreement Nominated development candidate for wholly-owned masked T cell engager program targeting CLDN18.2 Appoints Sara Bonstein as chair of board of directors WALTHAM, Mass., Jan. 08, 2026 (GLOBE ...
G-III Apparel Group Ltd: 1 director
A director at G-III Apparel Group Ltd sold 34,693 shares at 31.740USD and the significance rating of the trade was 83/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years...
Paramount Gold Expects to Receive Final Federal Approvals in January 2...
Paramount Gold Expects to Receive Final Federal Approvals in January 2026 for its High Grade Grassy Mountain Gold Project and Provides Corporate Update on 2025 Achievements WINNEMUCCA, Nev., Dec. 16, 2025 (GLOBE NEWSWIRE) -- Paramount Gold Nevada Corp. (NYSE American: PZG) (“Paramount” or the “Company”) announces today that the U.S. Bureau of Land Management (“BLM”) has confirmed that the final Environmental Impact Statement (“EIS”) and Record of Decision (“ROD”) for the Grassy Mountain Gold Project are scheduled to be issued in January 2026. Project and permitting timelines can be tracke...
Paramount Gold Announces the Voting Results of Its 2025 Annual General...
Paramount Gold Announces the Voting Results of Its 2025 Annual General Meeting WINNEMUCCA, Nev., Dec. 15, 2025 (GLOBE NEWSWIRE) -- Paramount Gold Nevada Corp. (“Paramount” or the “Company”) (NYSE American: PZG) announces the results of the votes from its Annual General Meeting (“AGM”) of stockholders held on December 11, 2025. There were 78,338,726 shares outstanding and entitled to vote at the meeting as of the record date of October 16, 2025, of which, 46,146,357 shares or 58.91 % voted. The stockholders elected the following seven individuals to Paramount’s Board of Directors for a on...
G-III Apparel Group, Ltd. Reports Third Quarter Fiscal 2026 Results an...
G-III Apparel Group, Ltd. Reports Third Quarter Fiscal 2026 Results and Updates Fiscal 2026 Outlook; Initiates First Ever Quarterly Dividend Program Net Income Per Diluted Share of $1.84 and Non-GAAP Net Income Per Diluted Share of $1.90 for the Third Quarter, Both Exceeding GuidanceNet Sales of $988.6 Million for the Third QuarterRaises GAAP and Non-GAAP Net Income Per Diluted Share GuidanceMaintains Strong Cash and Availability PositionIntroduces First Ever Quarterly Dividend of $0.10 Per Share NEW YORK, Dec. 09, 2025 (GLOBE NEWSWIRE) -- G-III Apparel Group, Ltd. (NasdaqGS: GIII) (“G-I...
Paramount Gold Nevada Receives Draft Consolidated Permit Package From ...
Paramount Gold Nevada Receives Draft Consolidated Permit Package From the State of Oregon for the Grassy Mountain Gold Project WINNEMUCCA, Nev., Dec. 08, 2025 (GLOBE NEWSWIRE) -- Paramount Gold Nevada Corp. (NYSE American: PZG) (“Paramount” or the “Company”) announces today that The Oregon Department of Geology and Mineral Industries (“DOGAMI”) has published the draft consolidated permit package for the Grassy Mountain Gold Project on behalf of all state permitting and cooperating agencies. This represents the first time in Oregon’s history that a mining project has advanced through the ...
G-III Apparel Group Announces Date for Third Quarter Fiscal 2026 Resul...
G-III Apparel Group Announces Date for Third Quarter Fiscal 2026 Results NEW YORK, Dec. 02, 2025 (GLOBE NEWSWIRE) -- G-III Apparel Group, Ltd. (NASDAQ: GIII) today announced that it will release its third quarter fiscal 2026 earnings before the market opens on Tuesday, December 9, 2025. Management will host a conference call to discuss results at 8:30 a.m. ET that same day, followed by a question and answer session for the investment community. To participate via telephone, please register in advance at this link: . Upon registration, all telephone participants will receive a confirmatio...
- David Nierengarten
- Dennis Pak
- Martin Fan
- Jonathan Moreland
UEC URANIUM ENERGY CORP
TPVG TRIPLEPOINT VENTURE GROWTH BDC CORP
STAA STAAR SURGICAL CO.
OPK OPKO HEALTH INC.
LQDT LIQUIDITY SERVICES
LMAT LEMAITRE VASCULAR INC.
FAST FASTENAL COMPANY
BEN FRANKLIN RESOURCES INC.
SRTS SENSUS HEALTHCARE
RSSS RESEARCH SOLUTIONS
ULBI ULTRALIFE
EVLV EVOLV TECHNOLOGIES HLDGS INC
WEST WESTROCK COFFEE COMPANY LLC
SMRT SMARTRENT INC
NCDL NUVEEN CHURCHILL DIRECT LENDING CORP
SLS SELLAS LIFE SCIENCES GROUP INC
BATRK LIBERTY MEDIA CORP
ANNX ANNEXIN PHARMACEUTICALS AB (PUBL)
OESX ORION ENERGY SYSTEMS INC
- David Nierengarten
- Dennis Pak
- Martin Fan
- David Nierengarten
- Dennis Pak
- Martin Fan
Xilio Therapeutics Announces Pipeline and Business Updates and Third Q...
Xilio Therapeutics Announces Pipeline and Business Updates and Third Quarter 2025 Financial Results Reported late-breaking Phase 2 data at SITC for vilastobart demonstrating a 40% ORR in heavily pretreated patients with MSS mCRC without liver metastases and high plasma tumor mutational burden Presented Phase 1 data at SITC for efarindodekin alfa showing promising monotherapy anti-tumor activity and generally well-tolerated safety profile in patients with advanced solid tumors Announced new preclinical data at SITC for masked T cell engager programs supporting best-in-class potential and ...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.